Combined use of computational chemistry, NMR screening, and X‐ray crystallography for identification and characterization of fluorophilic protein environments
暂无分享,去创建一个
[1] F. Diederich,et al. A fluorine scan of non-peptidic inhibitors of neprilysin: Fluorophobic and fluorophilic regions in an enzyme active site , 2008 .
[2] W. R. Dolbier,et al. Guide to Fluorine NMR for Organic Chemists , 2009 .
[3] G. Klebe,et al. More than a simple lipophilic contact: a detailed thermodynamic analysis of nonbasic residues in the s1 pocket of thrombin. , 2009, Journal of molecular biology.
[4] M. Karplus,et al. Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. , 1993, Journal of medicinal chemistry.
[5] F. Diederich,et al. Fluorine in Pharmaceuticals: Looking Beyond Intuition , 2007, Science.
[6] Daniel R McMasters,et al. Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines. , 2003, Journal of medicinal chemistry.
[7] Anna Vulpetti,et al. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine. , 2009, Journal of the American Chemical Society.
[8] M. Zurini,et al. Use of organic solvents and small molecules for locating binding sites on proteins in solution* , 1999, Journal of biomolecular NMR.
[9] Markus Kroemer,et al. APRV - a program for automated data processing, refinement and visualization. , 2004, Acta crystallographica. Section D, Biological crystallography.
[10] Dagmar Ringe,et al. Analogous inhibitors of elastase do not always bind analogously , 1994, Nature Structural Biology.
[11] Paul Seiler,et al. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions. , 2003, Angewandte Chemie.
[12] A. J. Shaka,et al. Evaluation of a new broadband decoupling sequence: WALTZ-16 , 1983 .
[13] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[14] A. Bondi. van der Waals Volumes and Radii , 1964 .
[15] Claudio Dalvit,et al. Ligand- and substrate-based 19F NMR screening: Principles and applications to drug discovery , 2007 .
[16] G. Otting,et al. Organic solvents identify specific ligand binding sites on protein surfaces , 1997, Nature Biotechnology.
[17] M. Lascombe,et al. The crystal structure of oxylipin-conjugated barley LTP1 highlights the unique plasticity of the hydrophobic cavity of these plant lipid-binding proteins. , 2009, Biochemical and biophysical research communications.
[18] Sandor Vajda,et al. Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. , 2007, Journal of medicinal chemistry.
[19] M. Monshouwer,et al. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model. , 2008, Journal of medicinal chemistry.
[20] B. Honig,et al. Accurate First Principles Calculation of Molecular Charge Distributions and Solvation Energies from Ab Initio Quantum Mechanics and Continuum Dielectric Theory , 1994 .
[21] Hans Matter,et al. Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions. , 2005, Journal of medicinal chemistry.
[22] G. Cruciani,et al. Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field. , 2004, Journal of medicinal chemistry.
[23] G A Petsko,et al. Interaction of a peptidomimetic aminimide inhibitor with elastase. , 1995, Science.
[24] Peng Zhou,et al. Fluorine Bonding - How Does It Work In Protein-Ligand Interactions? , 2009, J. Chem. Inf. Model..
[25] D. Ringe,et al. Proteins in organic solvents. , 2001, Current opinion in structural biology.
[26] Hans Matter,et al. Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallography. , 2005, Journal of medicinal chemistry.
[27] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[28] Dima Kozakov,et al. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques , 2009, Bioinform..
[29] T. Prangé,et al. Interaction of the peptide CF3‐Leu‐Ala‐NH‐C6 H4‐CF3 (TFLA) with porcine pancreatic elastase. X‐ray studies at 1.8 Å , 1990, Journal of molecular recognition : JMR.
[30] Stefan Güssregen,et al. Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity. , 2009, Angewandte Chemie.
[31] Claudio Dalvit,et al. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. , 2003, Journal of the American Chemical Society.
[32] L. Sieker,et al. Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase. , 1982, Journal of molecular biology.
[33] Claudio Dalvit,et al. NMR methods in fragment screening: theory and a comparison with other biophysical techniques. , 2009, Drug discovery today.
[34] F. J. Luque,et al. Binding site detection and druggability index from first principles. , 2009, Journal of medicinal chemistry.
[35] G A Petsko,et al. Structural analysis of the active site of porcine pancreatic elastase based on the X-ray crystal structures of complexes with trifluoroacetyl-dipeptide-anilide inhibitors. , 1995, Biochemistry.
[36] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[37] Anna Vulpetti,et al. Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug Discovery , 2010, J. Chem. Inf. Model..
[38] B. Honig,et al. New Model for Calculation of Solvation Free Energies: Correction of Self-Consistent Reaction Field Continuum Dielectric Theory for Short-Range Hydrogen-Bonding Effects , 1996 .
[39] S. Meiboom,et al. Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .
[40] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[41] François Diederich,et al. Orthogonal multipolar interactions in structural chemistry and biology. , 2005, Angewandte Chemie.
[42] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[43] 胡昌明,et al. Reaction of Active Methylene Compounds with α-Fluoroalkyl Ketones or Esters: A Convenient Synthesis of 4-Trifluoromethylpyridines and meta-Trifluoromethylphenols , 1996 .
[44] G. Petsko,et al. Multiple solvent crystal structures: probing binding sites, plasticity and hydration. , 2006, Journal of molecular biology.
[46] Alan R. Katritzky,et al. Quantitative predictions of tautomeric equilibria for 2-, 3-, and 4-substituted pyridines in both the gas phase and aqueous solution: combination of AM1 with reaction field theory , 1989 .